Level Biotechnology (Taiwan) Analysis
| 3118 Stock | TWD 32.20 0.10 0.31% |
Level Biotechnology is fairly valued with Real Value of 32.29 and Hype Value of 32.2. The main objective of Level Biotechnology stock analysis is to determine its intrinsic value, which is an estimate of what Level Biotechnology is worth, separate from its market price. There are two main types of Level Biotechnology's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Level Biotechnology's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Level Biotechnology's stock to identify patterns and trends that may indicate its future price movements.
The Level Biotechnology stock is traded in Taiwan on Taiwan OTC Exchange, with the market opening at 09:00:00 and closing at 13:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Taiwan. Level Biotechnology is usually not traded on No Trading . Market opens only for Clearing & Settlement, Mid - autumn / Moon Festival, No Trading . Market opens only for Clearing & Settlement 2, Adjusted Holiday / Chinese New Year 's Eve, Chinese New Year 's Eve, Chinese New Year, Dragon Boat Festival, National Day of the Republic of China, Chinese New Year 2, Chinese New Year 3, Adjusted Holiday 1, Adjusted Holiday 2. Level Stock trading window is adjusted to Asia/Taipei timezone.
Level |
Level Stock Analysis Notes
About 32.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.71. In the past many companies with similar price-to-book ratios have beat the market. Level Biotechnology last dividend was issued on the 17th of June 2022. The entity had 1:1 split on the 5th of August 2011. Level Biotechnology Inc. markets and distributes cell culture, immunology, molecular biology products and biomedical precision equipment in Taiwan. The company was founded in 1989 and is headquartered in New Taipei City, Taiwan. LEVEL BIOTECHNOLOGY operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange. It employs 122 people. For more info on Level Biotechnology please contact the company at 886 2 2695 9935 or go to https://www.level.com.tw.Level Biotechnology Investment Alerts
| Level Biotechnology generated a negative expected return over the last 90 days | |
| About 32.0% of the company shares are owned by insiders or employees |
Level Biotechnology Thematic Classifications
In addition to having Level Biotechnology stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | BiotechBiotechnology and pharmaceuticals production and services |
Level Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 928.15 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Level Biotechnology's market, we take the total number of its shares issued and multiply it by Level Biotechnology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Level Profitablity
Level Biotechnology's profitability indicators refer to fundamental financial ratios that showcase Level Biotechnology's ability to generate income relative to its revenue or operating costs. If, let's say, Level Biotechnology is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Level Biotechnology's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Level Biotechnology's profitability requires more research than a typical breakdown of Level Biotechnology's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.1 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.11 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.11. Technical Drivers
As of the 1st of December, Level Biotechnology secures the Mean Deviation of 0.4843, risk adjusted performance of (0.03), and Standard Deviation of 0.6895. Level Biotechnology technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Please verify Level Biotechnology value at risk, skewness, and the relationship between the maximum drawdown and potential upside to decide if Level Biotechnology is priced some-what accurately, providing market reflects its recent price of 32.2 per share.Level Biotechnology Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Level Biotechnology middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Level Biotechnology. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Level Biotechnology Outstanding Bonds
Level Biotechnology issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Level Biotechnology uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Level bonds can be classified according to their maturity, which is the date when Level Biotechnology has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Level Biotechnology Predictive Daily Indicators
Level Biotechnology intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Level Biotechnology stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Level Biotechnology Forecast Models
Level Biotechnology's time-series forecasting models are one of many Level Biotechnology's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Level Biotechnology's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Level Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Level Biotechnology prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Level shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Level Biotechnology. By using and applying Level Stock analysis, traders can create a robust methodology for identifying Level entry and exit points for their positions.
Level Biotechnology Inc. markets and distributes cell culture, immunology, molecular biology products and biomedical precision equipment in Taiwan. The company was founded in 1989 and is headquartered in New Taipei City, Taiwan. LEVEL BIOTECHNOLOGY operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange. It employs 122 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Level Biotechnology to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Additional Tools for Level Stock Analysis
When running Level Biotechnology's price analysis, check to measure Level Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Level Biotechnology is operating at the current time. Most of Level Biotechnology's value examination focuses on studying past and present price action to predict the probability of Level Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Level Biotechnology's price. Additionally, you may evaluate how the addition of Level Biotechnology to your portfolios can decrease your overall portfolio volatility.